Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.
- Provides an overview of an array of nanotechnology-based drug delivery systems
- Examines the design, synthesis and application of different nanocarriers in drug and gene delivery
- Provides an in-depth understanding of the design of targeted nanotherapeutics and technologies and its implication in various site-specific cancers
Pharmaceutical scientists, clinical researchers especially cancer researchers, biomedical and biotechnology professionals, graduate students and academic researchers in pharmaceutical science and materials science working in drug delivery and nanotechnology
1. Introduction: An Overview of the anatomy and physiology of the lung
2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug Resistance
3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer
4. Polymeric nanoparticles based drug delivery for lung cancer
5. Solid lipid nanoparticles based drug delivery for lung cancer
6. Liposomes and niosomes based drug delivery for lung cancer
7. Dendrimers based drug delivery for lung cancer
8. Micelles based drug delivery for lung cancer
9. Nanoemulsions based drug delivery for lung cancer
10. Nanomedicine-based inhalation treatments for lung cancer
11. Towards development of novel diagnostic nano-imaging platform for lung cancer
12. Hydrogel based drug delivery for lung cancer
13. Quantum dots based drug delivery for lung cancer
- No. of pages:
- © Academic Press 2019
- 31st January 2019
- Academic Press
- Paperback ISBN:
- eBook ISBN:
Dr. Prashant Kesharwani is Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He is a recipient of several internationally acclaimed awards viz “Ramanujan Fellowship, DST, India-2017”, “Excellence Research Award-2014”, “Young Innovator Award (Gold medal)-2012”, “International Travel Award/Grant from DST (New Delhi), and INSA (CCSTDS, Chennai)-2012”. He has received ICMR Senior Research Fellowship (in PhD) and AICTE Junior Research Fellowship (in M. Pharm.). After his doctorate, he worked as postdoctoral fellows in the Wayne State University, Detroit (Michigan, USA). Dr. Kesharwani subsequently joined the School of Pharmacy, International Medical University (Malaysia) as lecturer in Pharmaceutical Technology. Subsequently he joined Central Drug Research Institute (CDRI), Lucknow as Ramanujan Fellow. Dr. Kesharwani is a co-author on more than 120 publications in high impact factor international journals and multiple international books.
Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.